CDC to Grant Exclusive License for Folic Acid Delivery in Contraceptives

Summary

The Centers for Disease Control and Prevention is considering granting a worldwide, limited-use license to Johnson & Johnson for administering folic acid in hormonal replacement or contraceptive compositions, as outlined in patent rights assigned to Ortho-McNeil Pharmaceutical and the US government.